In this article, you’ll learn why word of mouth patient referrals are among the most powerful patient acquisition tools to help grow your practice. For providers, word-of-mouth referrals are the gold standard of marketing. That’s because patients place a high value on social proof and personal stories from other patients. In fact, many new patients […]
Growth Strategies, Patient Engagement, Wellbe Insights
How Patient Engagement Directly Results in Patient Retention
27
Mar
Mar
Patient engagement is one of the most effective ways to boost patient retention for any clinical practice. According to Emergen Research, the patient engagement solutions market will be worth $41.2 billion by 2027. That’s no mistake: healthcare providers and systems are increasingly seeing the value of patient engagement for improving health outcomes and increasing their […]
The epitome of an entrepreneur, Mark has seen the peaks and valleys of starting, operating, and assuming the risks of a new venture. He’s come up against payroll, had a few bad hires, and even swept the floors early on. Collectively, Mark’s companies have done over $360 million in sales and raised more than $38 million in venture capital, and he has successfully bought and/or sold eight companies.
James believes technology, when creatively applied, can improve our life experiences. Intrigued by the amazing potential for internet and mobile technology to engage us all, James created a business model to reshape personal health management.
Mike Splinter, an electrical engineer and innovator, has played a major role in driving advances in the high tech industry, with more than four decades of executive leadership experience including 12 years with Applied Materials, Inc. where he was served as chairman and CEO, and over 20 years with Intel, where he was executive vice president of sales and marketing, and executive vice president of the Technology and Manufacturing Group.
Mr. Baldwin was most recently Chairman and CEO of Baxa Corporation, a leader in devices, systems, and software for the handling, packaging, and tracking of fluid medications in a critical care setting. Under his leadership from 1997 until its sale to Baxter Corporation in 2011, the company sales grew from $25 million to over $170 million. As CEO, he led the eight-member board of directors and led a minority recap resulting in Goldman Sach’s private equity group owning 27% of the company. He was also an early investor and lead director in Pharmacy OneSource, an innovative software-as-a-service business that had a successful exit in 2010.